GO:0045725 positive regulation of glycogen biosynthetic process: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045725 describes any process that activates or increases the frequency, rate or extent of glycogen biosynthesis, the formation of the branched glucose polymer glycogen.
• Glycogen biosynthesis is positively regulated by hormonal and metabolic signals that promote glucose uptake, activate glycogen synthase, and inhibit glycogen phosphorylase.
• Key regulatory nodes include insulin/PI3K/AKT signaling, GSK3-mediated inhibition of glycogen synthase, and allosteric activation by glucose-6-phosphate.
• In immune cells, glycogen metabolism supports memory CD8+ T cell formation and longevity, linking GO:0045725 to adaptive immunity.
• Dysregulation of glycogen biosynthetic regulation contributes to insulin resistance, type 2 diabetes, and metabolic dysfunction in non-alcoholic fatty liver disease.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of genes controlling glycogen biosynthesis.
Description
Glycogen is a highly branched polymer of glucose that serves as a rapidly mobilizable energy reserve in animals, fungi, and bacteria. The process of glycogen biosynthesis is tightly controlled by a network of signaling pathways and allosteric effectors that ensure glycogen is synthesized when glucose is abundant and energy demand is low. GO:0045725, positive regulation of glycogen biosynthetic process, captures the upstream events that stimulate this anabolic pathway, including hormone-induced signaling cascades, kinase/phosphatase switches, and metabolite-driven allosteric activation. Understanding this regulatory node is essential because inappropriate activation or suppression of glycogen synthesis underlies major metabolic disorders such as insulin resistance and type 2 diabetes. Moreover, recent studies have revealed that glycogen metabolism is not restricted to classical metabolic tissues; it also operates in immune cells, where it influences memory CD8+ T cell development and function. The term therefore bridges classical biochemistry with modern immunometabolism and disease research.
positive regulation of glycogen biosynthetic process At A Glance
| GO ID | GO:0045725 |
|---|---|
| GO term | positive regulation of glycogen biosynthetic process |
| Ontology | biological_process |
| Synonym | activation of glycogen biosynthetic process; positive regulation of glycogen anabolism; positive regulation of glycogen biosynthesis; positive regulation of glycogen formation; positive regulation of glycogen synthesis; stimulation of glycogen biosynthetic process; up regulation of glycogen biosynthetic process; up-regulation of glycogen biosynthetic process; upregulation of glycogen biosynthetic process |
| Major function | Stimulates the formation of glycogen by activating glycogen synthase and promoting glucose storage |
| Key upstream regulators | Insulin/PI3K/AKT signaling, GSK3 inhibition, glucose-6-phosphate allosteric activation |
| Cellular context | Liver, skeletal muscle, and immune cells such as memory CD8+ T cells |
| Disease relevance | Insulin resistance, type 2 diabetes, non-alcoholic fatty liver disease, and immune memory defects |
What Is GO:0045725?
GO:0045725 is a biological process term defined as any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen. In practical terms, it encompasses the signaling and regulatory events that turn on glycogen synthesis, as opposed to the biosynthetic reactions themselves (which are covered by glycogen biosynthetic process, GO:0005978).
Why Is positive regulation of glycogen biosynthetic process Important in Cell Biology?
Positive regulation of glycogen biosynthesis is central to whole-body glucose homeostasis. After a meal, rising insulin levels activate signaling cascades that dephosphorylate and activate glycogen synthase while inhibiting glycogen phosphorylase, thereby channeling glucose into storage. Defects in this regulatory axis cause excessive hepatic glucose output and contribute to insulin resistance and type 2 diabetes. In skeletal muscle, impaired glycogen synthesis limits exercise capacity and is associated with mitochondrial dysfunction after excessive training. Beyond classical metabolism, glycogen biosynthesis supports memory CD8+ T cell formation, and its positive regulation is required for long-lived immunity. Thus, GO:0045725 is a convergence point for metabolic, endocrine, and immunological research.
• Maintains blood glucose homeostasis by promoting postprandial glycogen storage in liver and muscle.
• Insulin resistance and type 2 diabetes involve defective positive regulation of glycogen synthesis.
• Hepatic glycogen regulation is altered in non-alcoholic fatty liver disease (NAFLD).
• Glycogen metabolism supports memory CD8+ T cell development and longevity.
• Exercise-induced mitochondrial impairment can reduce glucose tolerance and glycogen storage capacity.
• Ketogenesis-derived beta-hydroxybutyrate influences T cell memory and may intersect with glycogen regulation.
• Plant glycogen-like starch biosynthesis is regulated by kinases such as GSK2 and SAPK8, highlighting evolutionary conservation.
• Glycolytic design principles inform how glycogen biosynthesis is integrated with energy metabolism.
• Compartmentalization of glycogen with the pentose phosphate pathway in memory T cells reveals spatial regulation.
• Targeting positive regulators of glycogen synthesis is a therapeutic strategy for metabolic disease.
What Happens During positive regulation of glycogen biosynthetic process?
Hormonal and signaling activation
In simple terms: Insulin and other signals tell the cell to store glucose as glycogen.
Positive regulation of glycogen biosynthesis begins with extracellular signals such as insulin, which activates the PI3K/AKT pathway. AKT phosphorylates and inhibits GSK3, relieving GSK3-mediated inhibitory phosphorylation of glycogen synthase. This cascade increases the active, dephosphorylated form of glycogen synthase, promoting glycogen chain elongation. In NAFLD models, VEGFB ameliorates insulin resistance via the PI3K/AKT signal pathway, indirectly supporting glycogen synthesis.
Allosteric activation by glucose-6-phosphate
In simple terms: A glucose metabolite directly flips the switch on glycogen synthase.
Glucose-6-phosphate (G6P) acts as a potent allosteric activator of glycogen synthase, stabilizing the active conformation even when the enzyme is phosphorylated. This provides a feed-forward mechanism: when glucose enters the cell and is converted to G6P, glycogen synthesis is stimulated. In memory CD8+ T cells, glucose-1-phosphate promotes compartmentalization of glycogen with the pentose phosphate pathway, linking metabolite availability to glycogen regulation.
Dephosphorylation by protein phosphatases
In simple terms: Phosphatases remove inhibitory phosphate groups to turn glycogen synthase on.
Protein phosphatase 1 (PP1) dephosphorylates glycogen synthase and glycogen phosphorylase, simultaneously activating synthesis and inhibiting degradation. The targeting of PP1 to glycogen particles is mediated by regulatory subunits such as GM and GL, which are themselves regulated by phosphorylation. This coordinated dephosphorylation is a hallmark of positive regulation of glycogen biosynthesis.
Transcriptional and metabolic reprogramming
In simple terms: Cells can also make more of the enzymes needed for glycogen storage.
Longer-term positive regulation involves increased expression of genes encoding glycogen synthase, branching enzyme, and glucose transporters. In memory CD8+ T cells, a Pck1-directed glycogen metabolic program regulates formation and maintenance, showing that transcriptional rewiring of glycogen metabolism supports cell fate. Ketogenesis-generated beta-hydroxybutyrate acts as an epigenetic regulator of CD8+ T cell memory, potentially influencing glycogen gene expression.
Compartmentalization and spatial control
In simple terms: Glycogen synthesis happens in specific cellular locations to coordinate with other pathways.
Recent evidence shows that glycogen and the pentose phosphate pathway are compartmentalized in CD8+ memory T cells, with glucose-1-phosphate promoting this organization. Such spatial regulation ensures that glycogen synthesis is coupled to NADPH production and redox balance. This adds a layer of positive regulation beyond classical allosteric and covalent mechanisms.
Key Genes Involved in GO:0045725 positive regulation of glycogen biosynthetic process
The following genes and proteins are central to the positive regulation of glycogen biosynthetic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| INSR | Insulin receptor; initiates signaling that activates glycogen synthesis | Target for insulin resistance studies |
| PIK3CA | Catalytic subunit of PI3K; generates PIP3 to recruit AKT | Key node in PI3K/AKT pathway |
| AKT1 | Phosphorylates and inhibits GSK3, activating glycogen synthase | Central kinase in insulin signaling |
| GSK3A | Phosphorylates and inhibits glycogen synthase | Negative regulator; target for activation of synthesis |
| GSK3B | Phosphorylates and inhibits glycogen synthase | Negative regulator; drug target |
| GYS1 | Muscle glycogen synthase; rate-limiting enzyme | Direct effector of glycogen synthesis |
| GYS2 | Liver glycogen synthase; rate-limiting enzyme | Direct effector of hepatic glycogen synthesis |
| PPP1R3A | Regulatory subunit of PP1 targeting to glycogen | Mediates dephosphorylation of glycogen synthase |
| PPP1R3B | Liver-specific PP1 regulatory subunit | Controls hepatic glycogen synthesis |
| PYGL | Liver glycogen phosphorylase; degrades glycogen | Inhibition promotes glycogen storage |
| PYGM | Muscle glycogen phosphorylase; degrades glycogen | Inhibition promotes glycogen storage |
| PCK1 | Phosphoenolpyruvate carboxykinase; directs glycogen metabolic program | Regulates memory CD8+ T cell formation |
| VEGFB | Vascular endothelial growth factor B; ameliorates insulin resistance | Modulates PI3K/AKT and glycogen synthesis |
| SLC2A4 | GLUT4 glucose transporter; mediates glucose uptake | Upstream of glycogen synthesis |
| HK2 | Hexokinase 2; phosphorylates glucose to G6P | Provides G6P for allosteric activation |
| PGM1 | Phosphoglucomutase 1; converts G6P to G1P | Supplies substrate for glycogen synthase |
| UGP2 | UDP-glucose pyrophosphorylase; produces UDP-glucose | Essential substrate for glycogen synthesis |
How Is positive regulation of glycogen biosynthetic process Regulated?
Positive regulation of glycogen biosynthesis is controlled by a multilayered network. Insulin binding to its receptor activates PI3K/AKT signaling, which inhibits GSK3 and thereby prevents inhibitory phosphorylation of glycogen synthase. Protein phosphatase 1, targeted by regulatory subunits such as PPP1R3A and PPP1R3B, dephosphorylates and activates glycogen synthase while inactivating glycogen phosphorylase. Allosterically, glucose-6-phosphate binds and activates glycogen synthase independently of phosphorylation status. In immune cells, Pck1-directed metabolic programs and ketone body beta-hydroxybutyrate modulate glycogen metabolism and memory T cell development. Additionally, glucose-1-phosphate promotes compartmentalization of glycogen with the pentose phosphate pathway, adding spatial control. Plant homologs such as OsNAC016 interact with GSK2 and SAPK8 to regulate starch biosynthesis, indicating deep evolutionary conservation of kinase-mediated regulation.
positive regulation of glycogen biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AKT1 | Insulin resistance, type 2 diabetes | Knockout or point-mutation in hepatocytes |
| GSK3B | Type 2 diabetes, NAFLD | Knock-in of constitutively active mutant |
| PCK1 | Impaired CD8+ memory T cell formation | Conditional knockout in mouse T cells |
| VEGFB | NAFLD and insulin resistance | Overexpression in liver |
| PPP1R3A | Glycogen storage disease, insulin resistance | Knockout in skeletal muscle |
Insulin resistance and type 2 diabetes
Defective positive regulation of glycogen biosynthesis is a hallmark of insulin resistance. Impaired PI3K/AKT signaling leads to reduced GSK3 inhibition, keeping glycogen synthase phosphorylated and inactive, which contributes to hyperglycemia. In non-alcoholic fatty liver disease, VEGFB ameliorates insulin resistance via the PI3K/AKT pathway, highlighting a potential therapeutic target to restore glycogen synthesis.
Metabolic dysfunction in skeletal muscle
Excessive exercise training causes mitochondrial functional impairment and decreases glucose tolerance in healthy volunteers, which may involve reduced capacity for glycogen synthesis. Proper regulation of glycogen biosynthesis is required for muscle energy homeostasis and exercise performance.
Immune memory and T cell function
Glycogen metabolism is critical for CD8+ memory T cell formation and maintenance. A Pck1-directed glycogen metabolic program regulates these processes, and its disruption impairs long-lived immunity. Ketogenesis-generated beta-hydroxybutyrate acts as an epigenetic regulator of CD8+ T cell memory, linking metabolic state to gene expression. Compartmentalization of glycogen with the pentose phosphate pathway further supports memory T cell function.
Plant drought tolerance and architecture
Although not a human disease, the regulation of starch (a glycogen-like polymer) biosynthesis in plants is controlled by kinases such as GSK2 and SAPK8. OsNAC016 regulates plant architecture and drought tolerance by interacting with these kinases, demonstrating conserved regulatory principles.
From positive regulation of glycogen biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of AKT1 abolish insulin-stimulated glycogen synthesis? | AKT1 knockout cell line (e.g., HepG2) |
| Does a constitutively active GSK3B mutant suppress glycogen accumulation? | GSK3B point-mutation knock-in |
| Can overexpression of VEGFB restore glycogen synthesis in NAFLD? | VEGFB overexpression in primary hepatocytes |
| Is PCK1 required for memory CD8+ T cell glycogen program? | PCK1 conditional knockout mouse |
| Does glucose-1-phosphate promote glycogen compartmentalization? | Knock-in of tagged PGM1 for imaging |
| What is the role of PPP1R3A in muscle glycogen synthesis? | PPP1R3A knockout muscle cells |
How to Study the positive regulation of glycogen biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C-glucose tracing | Flux through glycogen synthesis | Quantify positive regulation in hepatocytes |
| Phospho-Western blot | Phosphorylation of GS and GSK3 | Assess insulin signaling |
| Glycogen synthase activity assay | Enzyme activity with/without G6P | Measure allosteric activation |
| CRISPR knockout screen | Genes required for glycogen accumulation | Discover novel regulators |
| RNA-seq | Transcriptional changes in glycogen genes | Evaluate long-term regulation |
| Proteomics | Protein interactions and modifications | Identify PP1 regulatory subunits |
| Imaging of glycogen particles | Subcellular localization | Study compartmentalization |
| Metabolomics | G6P, G1P, UDP-glucose levels | Link metabolites to regulation |
Metabolic flux analysis
Isotope tracing with 13C-glucose followed by mass spectrometry measures the rate of glycogen synthesis and identifies pathway intermediates. This method directly quantifies the impact of positive regulators on flux.
Western blotting and phospho-specific antibodies
Phosphorylation status of glycogen synthase (e.g., Ser641) and GSK3 (Ser9) is assessed by immunoblotting to determine whether regulatory pathways are activated.
Enzymatic activity assays
Glycogen synthase activity is measured in cell lysates using UDP-glucose as substrate, with and without glucose-6-phosphate to assess allosteric activation.
CRISPR screening and transcriptomics
Genome-wide CRISPR knockout screens combined with RNA-seq can identify novel positive regulators of glycogen biosynthesis. This approach is powerful for discovering unanticipated genes.
How CRISPR Can Be Used to Study GO:0045725 positive regulation of glycogen biosynthetic process
Knockout
CRISPR knockout of positive regulators such as AKT1, GYS1, or PPP1R3A abolishes or reduces glycogen synthesis, providing causal evidence for their role in GO:0045725. Knockout of negative regulators like GSK3B increases glycogen accumulation, confirming their inhibitory function.
Point Mutation
Point mutations can mimic phosphorylation or dephosphorylation states. For example, knock-in of a phospho-deficient GYS1 mutant prevents inhibitory phosphorylation and constitutively activates glycogen synthesis. Similarly, kinase-dead AKT1 mutants block insulin-stimulated glycogen regulation.
Knock-in
Tagged knock-in of endogenous genes (e.g., GFP-GYS1) allows real-time imaging of glycogen synthase localization and dynamics. Knock-in of disease-associated variants can model human metabolic disorders.
Overexpression
Overexpression of VEGFB or constitutively active AKT1 enhances glycogen synthesis and ameliorates insulin resistance in cellular models. Overexpression of PCK1 promotes the glycogen metabolic program in CD8+ T cells.
How EDITGENE Supports positive regulation of glycogen biosynthetic process Research
Researchers studying positive regulation of glycogen biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in glycogen accumulation, how specific mutations alter enzyme activity, or where the protein localizes within the cell. EDITGENE provides end-to-end CRISPR services to answer these questions with precision.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of glycogen biosynthetic process research.
Frequently Asked Questions About positive regulation of glycogen biosynthetic process
What is GO:0045725?
GO:0045725 is the Gene Ontology term for positive regulation of glycogen biosynthetic process, defined as any process that activates or increases the frequency, rate or extent of glycogen formation.
What genes are involved in positive regulation of glycogen biosynthetic process?
Key genes include AKT1, GSK3A, GSK3B, GYS1, GYS2, PPP1R3A, PPP1R3B, PCK1, and VEGFB, among others.
How is glycogen biosynthesis activated by insulin?
Insulin activates PI3K/AKT signaling, which inhibits GSK3, leading to dephosphorylation and activation of glycogen synthase.
What is the role of glucose-6-phosphate in glycogen synthesis?
Glucose-6-phosphate allosterically activates glycogen synthase, promoting glycogen synthesis even when the enzyme is phosphorylated.
Which diseases are linked to defective glycogen biosynthesis regulation?
Insulin resistance, type 2 diabetes, non-alcoholic fatty liver disease, and impaired CD8+ memory T cell formation are linked to dysregulation of this process.
How can CRISPR be used to study glycogen biosynthesis?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes in the glycogen regulatory network.
What methods measure glycogen synthesis rates?
13C-glucose tracing, glycogen synthase activity assays, and phospho-Western blots are commonly used.
Is glycogen metabolism important in immune cells?
Yes, a Pck1-directed glycogen metabolic program regulates memory CD8+ T cell formation and maintenance.
What is the difference between glycogen biosynthetic process and its positive regulation?
Glycogen biosynthetic process (GO:0005978) covers the enzymatic reactions, while positive regulation (GO:0045725) covers the upstream signals that activate those reactions.
Can plant models inform human glycogen regulation?
Yes, conserved kinases such as GSK2 and SAPK8 regulate starch biosynthesis in plants, providing evolutionary insights.
Conclusion
GO:0045725, positive regulation of glycogen biosynthetic process, is a critical biological process that integrates hormonal, metabolic, and transcriptional signals to control glycogen storage. Its dysregulation contributes to insulin resistance, type 2 diabetes, and immune memory defects. Advances in CRISPR-based models and metabolic flux analysis are uncovering new regulatory nodes, offering promising therapeutic targets. Continued research into this process will deepen our understanding of energy homeostasis and disease.
References
- 1. Li Y et al.. 2024. VEGFB ameliorates insulin resistance in NAFLD via the PI3K/AKT signal pathway.. J Transl Med 22(1):976 PMID: 39468621
- 2. Zhou Y et al.. 2025. Glucose-1-phosphate promotes compartmentalization of glycogen with the pentose phosphate pathway in CD8(+) memory T cells.. Mol Cell 85(13):2535-2549.e10 PMID: 40499549
- 3. Flockhart M et al.. 2021. Excessive exercise training causes mitochondrial functional impairment and decreases glucose tolerance in healthy volunteers.. Cell Metab 33(5):957-970.e6 PMID: 33740420
- 4. Wu Q et al.. 2022. OsNAC016 regulates plant architecture and drought tolerance by interacting with the kinases GSK2 and SAPK8.. Plant Physiol 189(3):1296-1313 PMID: 35333328
- 5. Zhang H et al.. 2020. Ketogenesis-generated β-hydroxybutyrate is an epigenetic regulator of CD8(+) T-cell memory development.. Nat Cell Biol 22(1):18-25 PMID: 31871320
- 6. Boiteux A et al.. 1981. Design of glycolysis.. Philos Trans R Soc Lond B Biol Sci 293(1063):5-22 PMID: 6115423
- 7. Ma R et al.. 2018. A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8(+) T cells.. Nat Cell Biol 20(1):21-27 PMID: 29230018
- 8. Shulman RG et al.. 1995. In vivo regulation of muscle glycogen synthase and the control of glycogen synthesis.. Proc Natl Acad Sci U S A 92(19):8535-42 PMID: 7567971
